Elaine Sullivan

Elaine Sullivan is the founder of Carrick Therapeutics Ltd.
(founded in 2015) and Curadh Pharmaceuticals Ltd.
(founded in 2020).
She held the title of Chief Executive Officer at Carrick Therapeutics Ltd.
from 2015 to 2019.
At Curadh Pharmaceuticals Ltd., she also held the title of Chief Executive Officer.
Dr. Sullivan's current job(s) include being an Independent Non-Executive Director at IP Group Plc since 2015, a Director at Nykode Therapeutics ASA since 2022, a Non-Executive Director at IP Group Plc, a Senior Independent Non-Executive Director at hVIVO PLC since 2020, a Director at Zealand Pharma A since 2024, and a Member-Supervisory Board at Evotec SE since 2015.
Dr. Sullivan's former job(s) include being the Chief Executive Officer at Keltic Pharma Therapeutics Ltd.
from 2021 to 2023, a Non-Executive Director at hVIVO Ltd.
from 2020 to 2023, an Independent Director at Active Biotech AB, the VP-Global External Research & Development at Eli Lilly & Co. from 2011 to 2014, and the Vice President-Research & Development at AstraZeneca PLC from 1995 to 2010.
Dr. Sullivan's education history includes an undergraduate degree from the University of Glasgow in 1983 and a doctorate degree from The University of Edinburgh in 1987.